Free Trial

Semler Scientific, Inc. (NASDAQ:SMLR) Short Interest Down 15.1% in January

Semler Scientific logo with Medical background

Semler Scientific, Inc. (NASDAQ:SMLR - Get Free Report) was the target of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 1,180,000 shares, a decline of 15.1% from the December 31st total of 1,390,000 shares. Based on an average daily volume of 730,200 shares, the days-to-cover ratio is presently 1.6 days. Approximately 15.7% of the company's stock are short sold.

Hedge Funds Weigh In On Semler Scientific

Several hedge funds and other institutional investors have recently bought and sold shares of the company. IFP Advisors Inc purchased a new position in Semler Scientific in the fourth quarter valued at about $54,000. Shariaportfolio Inc. grew its holdings in shares of Semler Scientific by 4.5% during the fourth quarter. Shariaportfolio Inc. now owns 160,453 shares of the company's stock valued at $8,664,000 after buying an additional 6,837 shares in the last quarter. Global Retirement Partners LLC boosted its holdings in shares of Semler Scientific by 62.5% during the fourth quarter. Global Retirement Partners LLC now owns 1,300 shares of the company's stock worth $70,000 after purchasing an additional 500 shares during the period. Sanctuary Advisors LLC increased its position in Semler Scientific by 13.2% in the 4th quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company's stock worth $261,000 after purchasing an additional 584 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its stake in shares of Semler Scientific by 633.1% in the 4th quarter. Principal Financial Group Inc. now owns 112,487 shares of the company's stock valued at $6,074,000 after purchasing an additional 97,144 shares during the last quarter. 49.37% of the stock is owned by institutional investors and hedge funds.

Semler Scientific Trading Up 1.1 %

Semler Scientific stock traded up $0.55 during mid-day trading on Wednesday, hitting $51.79. The company had a trading volume of 181,658 shares, compared to its average volume of 464,515. The company has a market capitalization of $480.09 million, a price-to-earnings ratio of 25.26 and a beta of 1.17. Semler Scientific has a 12-month low of $20.88 and a 12-month high of $81.56. The company's fifty day moving average is $59.55 and its 200-day moving average is $41.33.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The business had revenue of $13.51 million during the quarter.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital upped their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the company a "buy" rating in a report on Friday, January 24th.

View Our Latest Stock Analysis on Semler Scientific

Semler Scientific Company Profile

(Get Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Featured Articles

Should You Invest $1,000 in Semler Scientific Right Now?

Before you consider Semler Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.

While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Cashes In on Stocks—Here’s How You Can Too!
5 Stocks to BUY NOW in March 2025
Archer Aviation: Sinking Now, Soaring Soon?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines